Cardia Bioplastics (ASX:CNN) EV-to-EBIT : -0.87 (As of Apr. 30, 2024)

View and export this data going back to . Start your Free Trial

What is Cardia Bioplastics EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Cardia Bioplastics's Enterprise Value is A$5.81 Mil. Cardia Bioplastics's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was A$-6.66 Mil. Therefore, Cardia Bioplastics's EV-to-EBIT for today is -0.87.

The historical rank and industry rank for Cardia Bioplastics's EV-to-EBIT or its related term are showing as below:

ASX:CNN' s EV-to-EBIT Range Over the Past 10 Years
Min: -148.69 Med: -3.39 Max: 396.26
Current: -2.23

During the past 13 years, the highest EV-to-EBIT of Cardia Bioplastics was 396.26. The lowest was -148.69. And the median was -3.39.

ASX:CNN's EV-to-EBIT is ranked worse than
100% of 330 companies
in the Packaging & Containers industry
Industry Median: 13.545 vs ASX:CNN: -2.23

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Cardia Bioplastics's Enterprise Value for the quarter that ended in Dec. 2023 was A$0.00 Mil. Cardia Bioplastics's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was A$-6.66 Mil. Cardia Bioplastics's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 was %.

Cardia Bioplastics EV-to-EBIT Historical Data

The historical data trend for Cardia Bioplastics's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cardia Bioplastics EV-to-EBIT Chart

Cardia Bioplastics Annual Data

Trend

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

EV-to-EBIT

Get a 7-Day Free Trial

-3.55

-24.02

285.89

-18.22

-3.83

Cardia Bioplastics Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
EV-to-EBIT	Get a 7-Day Free Trial															-	-18.22	-	-3.83	-

Competitive Comparison of Cardia Bioplastics's EV-to-EBIT

For the Packaging & Containers subindustry, Cardia Bioplastics's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Cardia Bioplastics's EV-to-EBIT Distribution in the Packaging & Containers Industry

For the Packaging & Containers industry and Consumer Cyclical sector, Cardia Bioplastics's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Cardia Bioplastics's EV-to-EBIT falls into.

Cardia Bioplastics EV-to-EBIT Calculation

Cardia Bioplastics's EV-to-EBIT for today is calculated as:

EV-to-EBIT	=	Enterprise Value (Today)	/	EBIT (TTM)
	=	5.807	/	-6.658
	=	-0.87

Cardia Bioplastics's current Enterprise Value is A$5.81 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Cardia Bioplastics's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was A$-6.66 Mil.

Cardia Bioplastics (ASX:CNN) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Cardia Bioplastics's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Dec. 2023 )	=	EBIT	/	Enterprise Value (Q: Dec. 2023 )
	=	-6.658	/	0
	=	%

Cardia Bioplastics's Enterprise Value for the quarter that ended in Dec. 2023 was A$0.00 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Cardia Bioplastics's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was A$-6.66 Mil.

Cardia Bioplastics EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Cardia Bioplastics's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

Cardia Bioplastics (ASX:CNN) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Consumer Cyclical » Packaging & Containers » Cardia Bioplastics Ltd (ASX:CNN) » Definitions » EV-to-EBIT

Comparable Companies

Traded in Other Exchanges

SES:Australia

Address

247 Ferntree Gully Road, Unit 1, Mount Waverley, Melbourne, VIC, AUS, VIC 3149

Website

https://www.secosgroup.com.au

SECOS Group Ltd is an Australian developer and manufacturer of sustainable packaging materials. . Business operating segment includes the manufacture and distribution of polyethylene films, renewable resource-based resins, and finished products. It supplies proprietary biodegradable resins, packaging products cast films to a customer base spread globally.SECOS Global Application Development Centre is in Australia. Product Development Centre and manufacturing plant for resins and finished products in China and resins plant in Malaysia. It also has manufacturing plants for cast films in Malaysia. It conducts sales via geographical regions that include Australia, Asia, America, Europe, and Africa. Asia generates maximum revenue for the company.

Cardia Bioplastics (ASX:CNN) Headlines

No Headlines